AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 23- Open
- $144.52
- 52-wk high
- $155.38
- High
- $147.91
- 52-wk low
- $106.44
- Low
- $143.50
- Prev close
- $143.44
Smart money
Earnings
Earnings came in 4.5% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.77B | $7.92B | $6.96B | $7.80B |
| Cost of what it sold | $1.57B | $1.62B | $1.45B | $1.58B |
| Gross profit | $6.20B | $6.30B | $5.51B | $6.22B |
| What it spent | ||||
| Research and development | $1.35B | $1.58B | $1.37B | $1.76B |
| Sales and admin | $528.0M | $652.0M | $553.0M | $1.92B |
| Other operating costs | $999.0M | $1.08B | $1.00B | $12.93B |
| Total operating expenses | $2.87B | $3.31B | $2.93B | $16.62B |
| What was left | ||||
| Operating profit | $3.33B | $2.99B | $2.69B | -$10.39B |
| Interest on debt | $256.0M | $255.0M | $240.0M | $247.0M |
| Profit before tax | $3.64B | $2.08B | $2.58B | -$10.25B |
| Tax | $589.0M | -$105.0M | $559.0M | $242.0M |
| Net profit | $3.05B | $2.18B | $2.02B | -$10.50B |
| EBITDA | $4.58B | $3.02B | $3.51B | -$10.01B |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
73overbought
20D volatility
29%annualized
52-week range
$106.44$155.38
20D support
News
What the news says
50 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Eupraxia Pharmaceuticals Market Sentiment
NeutralAug 20Gilead Sciences Stock Surges 11%, With A 7-Day Winning Spree
BullishAug 20Gilead Sciences Stock Climbs 11% On A 7-Day Winning Streak
NeutralAug 20
